AAPL309.12-1.54 (-0.50%) ▼|ABBV253.27-1.37 (-0.54%) ▼|ABT95.01-0.81 (-0.85%) ▼|ACN140.12-1.99 (-1.40%) ▼|ADBE217.91-3.63 (-1.64%) ▼|AMAT575.47+20.97 (+3.78%) ▲|AMD519.80+3.69 (+0.72%) ▲|AMGN367.34-0.77 (-0.21%) ▼|AMT165.02-0.24 (-0.14%) ▼|AMZN242.13-3.85 (-1.57%) ▼|AVGO385.48+14.70 (+3.96%) ▲|AXP342.18-7.40 (-2.12%) ▼|BA227.95-3.74 (-1.61%) ▼|BAC59.17-0.70 (-1.16%) ▼|BKNG175.20-6.75 (-3.71%) ▼|BLK994.00-15.43 (-1.53%) ▼|BMY57.80-0.17 (-0.29%) ▼|BNY152.34-0.57 (-0.37%) ▼|BRK-B501.49-2.52 (-0.50%) ▼|C139.59-1.18 (-0.84%) ▼|CAT946.52+6.40 (+0.68%) ▲|CL92.87-2.17 (-2.28%) ▼|CMCSA23.55+0.14 (+0.58%) ▲|COF197.42-5.48 (-2.70%) ▼|COP109.87+1.43 (+1.32%) ▲|COST957.15+9.65 (+1.02%) ▲|CRM165.50-4.02 (-2.37%) ▼|CSCO112.38+0.59 (+0.53%) ▲|CVS105.25+0.92 (+0.88%) ▲|CVX175.93+1.92 (+1.10%) ▲|DE597.48-6.13 (-1.02%) ▼|DHR191.72-2.47 (-1.27%) ▼|DIS97.21-0.27 (-0.28%) ▼|DUK128.31+0.09 (+0.07%) ▲|EMR135.46-2.45 (-1.78%) ▼|FDX311.44-1.44 (-0.46%) ▼|GD374.00-0.64 (-0.17%) ▼|GE361.30-5.68 (-1.55%) ▼|GEV1,093.93+16.85 (+1.56%) ▲|GILD135.86-0.50 (-0.37%) ▼|GM76.20+0.17 (+0.22%) ▲|GOOG359.82-3.80 (-1.05%) ▼|GOOGL362.48-4.56 (-1.24%) ▼|GS1,032.02-10.96 (-1.05%) ▼|HD333.12-12.09 (-3.50%) ▼|HON220.32-4.74 (-2.10%) ▼|IBM299.75-6.38 (-2.08%) ▼|INTC109.07-1.33 (-1.20%) ▼|INTU272.35-8.83 (-3.14%) ▼|ISRG418.34-8.96 (-2.10%) ▼|JNJ266.94-0.30 (-0.11%) ▼|JPM334.36-4.87 (-1.43%) ▼|KO84.43+0.38 (+0.45%) ▲|LIN528.14-10.09 (-1.87%) ▼|LLY1,228.19-7.37 (-0.60%) ▼|LMT532.13-3.25 (-0.61%) ▼|LOW213.47-7.44 (-3.37%) ▼|LRCX334.12+7.99 (+2.45%) ▲|MA522.71-8.91 (-1.68%) ▼|MCD277.59-4.62 (-1.64%) ▼|MDLZ59.35-0.87 (-1.44%) ▼|MDT82.63-1.20 (-1.43%) ▼|META605.14-10.44 (-1.70%) ▼|MMM155.21-2.80 (-1.77%) ▼|MO73.45+0.49 (+0.67%) ▲|MRK126.62-2.24 (-1.74%) ▼|MS219.80-2.24 (-1.01%) ▼|MSFT383.58-5.26 (-1.35%) ▼|MU950.94+12.56 (+1.34%) ▲|NEE88.29-0.18 (-0.20%) ▼|NFLX75.10-1.09 (-1.42%) ▼|NKE42.48-0.73 (-1.69%) ▼|NOW105.86-4.87 (-4.40%) ▼|NVDA197.40+0.47 (+0.24%) ▲|ORCL140.70-0.91 (-0.64%) ▼|PEP143.99-0.99 (-0.68%) ▼|PFE24.17+0.10 (+0.42%) ▲|PG149.50-3.25 (-2.13%) ▼|PLTR128.06-6.32 (-4.70%) ▼|PM187.76-0.04 (-0.02%) ▼|QCOM184.73+1.76 (+0.96%) ▲|RTX199.72-1.13 (-0.56%) ▼|SBUX102.36-1.25 (-1.21%) ▼|SCHW102.74+0.81 (+0.79%) ▲|SO97.03-0.26 (-0.27%) ▼|SPG224.02-3.17 (-1.40%) ▼|T21.12+0.03 (+0.12%) ▲|TMO509.24-7.38 (-1.43%) ▼|TMUS181.11-3.63 (-1.96%) ▼|TSLA394.39-8.51 (-2.11%) ▼|TXN299.91+6.61 (+2.25%) ▲|UBER73.84-0.50 (-0.67%) ▼|UNH429.40+1.21 (+0.28%) ▲|UNP283.00-0.12 (-0.04%) ▼|UPS111.20-0.76 (-0.68%) ▼|USB61.80-1.09 (-1.73%) ▼|V346.83-5.37 (-1.52%) ▼|VZ42.96+0.37 (+0.88%) ▲|WFC86.35-0.83 (-0.95%) ▼|WMT112.84+1.30 (+1.17%) ▲|XOM141.14-0.55 (-0.39%) ▼|AAPL309.12-1.54 (-0.50%) ▼|ABBV253.27-1.37 (-0.54%) ▼|ABT95.01-0.81 (-0.85%) ▼|ACN140.12-1.99 (-1.40%) ▼|ADBE217.91-3.63 (-1.64%) ▼|AMAT575.47+20.97 (+3.78%) ▲|AMD519.80+3.69 (+0.72%) ▲|AMGN367.34-0.77 (-0.21%) ▼|AMT165.02-0.24 (-0.14%) ▼|AMZN242.13-3.85 (-1.57%) ▼|AVGO385.48+14.70 (+3.96%) ▲|AXP342.18-7.40 (-2.12%) ▼|BA227.95-3.74 (-1.61%) ▼|BAC59.17-0.70 (-1.16%) ▼|BKNG175.20-6.75 (-3.71%) ▼|BLK994.00-15.43 (-1.53%) ▼|BMY57.80-0.17 (-0.29%) ▼|BNY152.34-0.57 (-0.37%) ▼|BRK-B501.49-2.52 (-0.50%) ▼|C139.59-1.18 (-0.84%) ▼|CAT946.52+6.40 (+0.68%) ▲|CL92.87-2.17 (-2.28%) ▼|CMCSA23.55+0.14 (+0.58%) ▲|COF197.42-5.48 (-2.70%) ▼|COP109.87+1.43 (+1.32%) ▲|COST957.15+9.65 (+1.02%) ▲|CRM165.50-4.02 (-2.37%) ▼|CSCO112.38+0.59 (+0.53%) ▲|CVS105.25+0.92 (+0.88%) ▲|CVX175.93+1.92 (+1.10%) ▲|DE597.48-6.13 (-1.02%) ▼|DHR191.72-2.47 (-1.27%) ▼|DIS97.21-0.27 (-0.28%) ▼|DUK128.31+0.09 (+0.07%) ▲|EMR135.46-2.45 (-1.78%) ▼|FDX311.44-1.44 (-0.46%) ▼|GD374.00-0.64 (-0.17%) ▼|GE361.30-5.68 (-1.55%) ▼|GEV1,093.93+16.85 (+1.56%) ▲|GILD135.86-0.50 (-0.37%) ▼|GM76.20+0.17 (+0.22%) ▲|GOOG359.82-3.80 (-1.05%) ▼|GOOGL362.48-4.56 (-1.24%) ▼|GS1,032.02-10.96 (-1.05%) ▼|HD333.12-12.09 (-3.50%) ▼|HON220.32-4.74 (-2.10%) ▼|IBM299.75-6.38 (-2.08%) ▼|INTC109.07-1.33 (-1.20%) ▼|INTU272.35-8.83 (-3.14%) ▼|ISRG418.34-8.96 (-2.10%) ▼|JNJ266.94-0.30 (-0.11%) ▼|JPM334.36-4.87 (-1.43%) ▼|KO84.43+0.38 (+0.45%) ▲|LIN528.14-10.09 (-1.87%) ▼|LLY1,228.19-7.37 (-0.60%) ▼|LMT532.13-3.25 (-0.61%) ▼|LOW213.47-7.44 (-3.37%) ▼|LRCX334.12+7.99 (+2.45%) ▲|MA522.71-8.91 (-1.68%) ▼|MCD277.59-4.62 (-1.64%) ▼|MDLZ59.35-0.87 (-1.44%) ▼|MDT82.63-1.20 (-1.43%) ▼|META605.14-10.44 (-1.70%) ▼|MMM155.21-2.80 (-1.77%) ▼|MO73.45+0.49 (+0.67%) ▲|MRK126.62-2.24 (-1.74%) ▼|MS219.80-2.24 (-1.01%) ▼|MSFT383.58-5.26 (-1.35%) ▼|MU950.94+12.56 (+1.34%) ▲|NEE88.29-0.18 (-0.20%) ▼|NFLX75.10-1.09 (-1.42%) ▼|NKE42.48-0.73 (-1.69%) ▼|NOW105.86-4.87 (-4.40%) ▼|NVDA197.40+0.47 (+0.24%) ▲|ORCL140.70-0.91 (-0.64%) ▼|PEP143.99-0.99 (-0.68%) ▼|PFE24.17+0.10 (+0.42%) ▲|PG149.50-3.25 (-2.13%) ▼|PLTR128.06-6.32 (-4.70%) ▼|PM187.76-0.04 (-0.02%) ▼|QCOM184.73+1.76 (+0.96%) ▲|RTX199.72-1.13 (-0.56%) ▼|SBUX102.36-1.25 (-1.21%) ▼|SCHW102.74+0.81 (+0.79%) ▲|SO97.03-0.26 (-0.27%) ▼|SPG224.02-3.17 (-1.40%) ▼|T21.12+0.03 (+0.12%) ▲|TMO509.24-7.38 (-1.43%) ▼|TMUS181.11-3.63 (-1.96%) ▼|TSLA394.39-8.51 (-2.11%) ▼|TXN299.91+6.61 (+2.25%) ▲|UBER73.84-0.50 (-0.67%) ▼|UNH429.40+1.21 (+0.28%) ▲|UNP283.00-0.12 (-0.04%) ▼|UPS111.20-0.76 (-0.68%) ▼|USB61.80-1.09 (-1.73%) ▼|V346.83-5.37 (-1.52%) ▼|VZ42.96+0.37 (+0.88%) ▲|WFC86.35-0.83 (-0.95%) ▼|WMT112.84+1.30 (+1.17%) ▲|XOM141.14-0.55 (-0.39%) ▼|
25 C
New York
Wednesday, July 8, 2026

Tag: press

RON FLEMING APPOINTED CHIEF EXECUTIVE OFFICER OF LAZYDAYS

TAMPA, Fla., July 9, 2025 /PRNewswire/ -- Lazydays Holdings, Inc. (NASDAQCM: GORV) ("Lazydays" or the "Company") announced today that Ron Fleming has been appointed...

APA Corporation Provides Second-Quarter 2025 Supplemental Information and Schedules Results Conference Call for August 7 at 10 a.m. Central Time

HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) today provided supplemental information regarding certain second-quarter 2025 financial and operational results. This information is intended only to provide additional information regarding current estimates management believes will affect results for the second-quarter 2025. It is provided to assist investors, analysts and others in formulating their own estimates, and is not intended to be a comprehensive presentation of all factors that will affect second-quarter 2025 results. Actual results and the impact of factors identified here may vary depending on the impact of other factors not identified here and are subject to finalization of the financial reporting process for second-quarter 2025.

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced a proposed public offering of $150 million of its common stock. All securities in the offering will be offered by Rhythm. In addition, Rhythm intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of common stock at the public offering price, less the underwriting discounts and commissions.

VSA Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, July 9, 2025 /PRNewswire/ -- TCTM Kids IT Education Inc. (NASDAQ: VSA) ("VSA" or the "Company"), an emerging technology services company, specializing in...

Motorsport Games Celebrates Significant Month for Le Mans Ultimate and Studio 397

MIAMI, July 09, 2025 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or “the Company”) is today reporting on reaching key operational milestones for Le Mans Ultimate, the official game of the FIA World Endurance Championship and the 24 Hours of Le Mans, and RaceControl, the Company’s matchmaking and online racing system, which provides enhanced access to online features, including championships, extended registration periods, and priority driver reports.

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality...


Daix (France), New York City (New York, United States), July 9, 2025
– Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced a leadership transition with the appointment of Jason Campagna, MD, PhD, as President of Research and Development (“R&D”) and Chief Medical Officer (“CMO”) and Martine Zimmermann, PharmD, as Executive Vice President (“EVP”) of Regulatory Affairs and Quality Assurance.

Allbirds Announces New Distributor Agreements Across the Eurasian Corridor

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- Allbirds, Inc. (Nasdaq: BIRD) today announced that it has signed three new distribution agreements for multiple countries throughout Eurasia as part of the Company’s strategy to build long-term scalable growth in overseas markets.

Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis

Data from Orbit and Cosmic studies expected around the end of the year
Data from Orbit and Cosmic studies expected around the end of the year

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial Results

Conference Call and Webcast Scheduled for Wednesday, July 30 SAN DIEGO, July 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it...

Matrixport Establishes Strategy XAUm Reserve, Remains Bullish on the Future of Tokenized Real-World Assets

SINGAPORE, July 09, 2025 (GLOBE NEWSWIRE) -- Matrixport, the world’s leading all-in-one hub for crypto financial services, announced that Matrixport Ventures, the investment arm of Matrixport, has completed a strategic reserve of XAUm equivalent to US$3 million, and plans to continue to increase its holdings of XAUm in stages. Matrixport will strengthen the stability of its financial reserves through the strategic reserve of XAUm, expand the depth of gold's application in the on-chain financial ecosystem, and comprehensively improve its product and service capabilities.

BCC Research Releases 2024 Protein Synthesis Research Review

"Driving Innovation and Sustainability: The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market...

BCC Research Releases 2024 Protein Synthesis Research Review

"Driving Innovation and Sustainability: The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market...

The Industry Flocks to the Fancy Food Show: Summer 2025 Event Saw 14% Increase in Attendee Registration, Nearly 2,500 Exhibitors from 59 Countries

NEW YORK, July 9, 2025 /PRNewswire/ -- The Specialty Food Association (SFA) brought together more than 32,000 industry professionals at the 69th Summer Fancy...

CIBC to Issue 7.000% NVCC AT1 Limited Recourse Capital Notes

TORONTO, July 9, 2025 /CNW/ - CIBC (TSX: CM) (NYSE: CM) today announced the public offering in the United States of US$750 million of 7.000% Fixed Rate Reset Limited...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress